22 Eylül 2026, Salı · 04:30 Piyasalar Kapalı
borsapanel.com Borsanın nabzı, tek panelde.
Abone Ol

Is Atlassian Stock Still a Buy After a 132% Three-Month Run? Here’s What Analysts Are Saying.

Is Atlassian Stock Still a Buy After a 132% Three-Month Run? Here’s What Analysts Are Saying.

Gian Estrada

Sun, September 20, 2026 at 5:48 PM GMT+3 5 min read

Is Atlassian Stock Still a Buy After a 132% Three-Month Run? Here's What Analysts Are Saying. ©TIKR

Key Takeaways

  • Atlassian stock has climbed 132% since mid-June, moving from roughly $83 to $192.02 by September 18, after a run of AI-driven software earnings beats flipped the sector's disruption narrative into a tailwind story.

  • Wall Street carries 21 buy ratings, 6 outperforms and 6 holds on Atlassian stock.

  • TIKR's mid case model still sees Atlassian stock reaching $279 by June 2031, a 45% total return that works out to 8% annualized.

  • The Street's mean target has only crept from $140 in June to $199 now, and the target-to-price ratio has collapsed from 180% to 104% as the stock did the analysts' work for them.

Why Atlassian Stock Has Soared 132% in Three Months on an AI Rerating

TEAM Stock Price: 3-Months (TIKR)

Atlassian (TEAM) stock has climbed 132% over the past three months, according to TIKR's own chart data, rising from roughly $83 in mid-June to $192.02 at the September 18 close. The move did not come from a single announcement. It came from three separate earnings prints, each one chipping away at a bear case that had cut Atlassian stock nearly in half earlier in 2026.

That bear case had a clear origin point. On July 14, IBM warned that customer spending was shifting away from software toward chips, servers and storage far faster than expected, and the stock fell 25% in a single session. Atlassian, ServiceNow and Adobe all sold off on the read-through, feeding a narrative that AI coding tools would let enterprises build their own replacements for platforms like Jira.

Atlassian answered that narrative directly on August 6, when fiscal fourth-quarter revenue rose 28% year over year to $1.77 billion, cloud revenue grew 31%, and remaining performance obligations jumped 44% to $4.82 billion. Shares that had closed at $113.32 the day before soared more than 28% in extended trading. Then Salesforce beat on August 19 and rolled out a Claude integration, sending its own stock up as much as 21.6% and lifting Atlassian alongside ServiceNow and Adobe. Snowflake followed on September 3 with a raised revenue forecast, and its 25% pop buoyed Atlassian, Salesforce and Adobe again.

CFO James Chuong made the case explicit at the Citi Global TMT Conference on September 9: "AI is going to be a tailwind for Atlassian as customers look to really drive more and more value out of AI, understanding that Atlassian delivers an incredible graph, our Teamwork Graph, that's what's really going to be powering AI across the enterprise." Three peer confirmations in five weeks turned that claim from a talking point into a pattern investors were willing to pay for.

Atlassian Stock's Rally Has Erased the Street's Upside Cushion

TEAM Stock Street Analysts Target (TIKR)

Wall Street carries 21 buy ratings, 6 outperforms and 6 holds on Atlassian stock as of September 18, with no underperforms or sells on the books. Separately, 31 analysts publish a price target on the name, and their mean sits at $199, just 4% above the current $192 price.

That 4% gap is thin by this stock's own recent history. Back on June 30, when Atlassian closed at $77.79, the mean target stood at $140.37 and the target-to-price ratio read 180%, meaning the Street saw 80% of upside still on the table. Analysts have barely moved that target since, nudging it up to $199 while the price nearly tripled. The stock did almost all of the closing itself.

That pattern flips the usual script. Analysts typically chase a rally with target hikes; here the target barely budged and the price simply ran up to meet it. It leaves Atlassian stock trading close to where the sell side already thought it belonged in June, with much less room left before the next move needs either new numbers or a new target.

TIKR Values Atlassian Stock at $279 by June 2031

TIKR's mid case model values Atlassian stock at $279 by June 2031, implying a 45% total return from the current price of $192, or 8% annualized over the next 4.8 years.

TEAM Stock Valuation Model Results (TIKR)

That 8% annualized figure is modest next to the 132% the stock has already delivered in three months, and it says the model treats the current price as having largely caught up to fair value rather than as a starting point for another leg like the one just finished.

The case for reaching $279 rests on the same Teamwork Graph and Rovo adoption story that drove the summer's rally holding up over years rather than quarters, with subscription ARR growth compounding off the 23% pace management posted in fiscal 2026. The Street's own target sitting just 4% above the price argues the market has already priced in a healthy chunk of that continuation, which is exactly why the model's implied return looks patient rather than explosive from here.

Should You Invest in Atlassian Corporation?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Atlassian Corporation stock and you'll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Atlassian Corporation alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Kaynak: Yahoo Finance
İlgili Haberler
Global Vietnam leader To Lam says positive negotiations with US on trade deal Investing.com · 12 dk önce Global Binance faces U.S. probe over potential Iran sanctions violations- Bloomberg Investing.com · 28 dk önce Global AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. Yahoo Finance · 7 saat önce Global Uranium Stocks Are Rallying. Why NXE Got Initiated At Overweight. Yahoo Finance · 7 saat önce Global Paramount Moves Closer to Clearing a Major Antitrust Hurdle. Here’s How That Impacts Its Warner Bros. Discovery Acquisition. Yahoo Finance · 7 saat önce

Yorumlar (0)

Giriş yaparak yorum yazabilirsin.

İlk yorumu sen yaz.